ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1251 • ACR Convergence 2020

    Assessing the Construct Validity of the Novel OMERACT Ultrasound Scoring System for Salivary Glands Target Lesions by Comparison with MRI in Patients with Sjögren’s Syndrome – An OMERACT Ultrasound Working Group Exercise

    Nevsun Inanc1, Sandrine Jousse-Joulin2, Kerem Abacar3, Çagatay Cimşit4, Canan Cimşit4, Maria D’Agostino5, Esperanza Naredo6, Alojzija Hocevar7, Stephanie Finzel8, Lene Terslev9, Annamaria Iagnocco10, Petra Hanova11, Wolfgang Schmidt12, Gonca Mumcu13 and George A. Bruyn14, 1Marmara University, School of Medicine, Division of Rheumatology, istanbul, Turkey, 2Rheumatology Department, Cavale Blanche Hospital and Brest Occidentale University, Brest, France, 3Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey, 4Marmara University School of Medicine, Radiology, Istanbul, Istanbul, Turkey, 5Université Versailles Saint Quentin, Ambroise Paré Hospital, Paris, France, 6Department of Rheumatology, Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz and Universidad Autónoma de Madrid, Madrid, Spain, 7University Medical Center, Rheumatology, Ljubljana, LJUBLJANA, Slovenia, 8Universitätsklinikum Freiburg, Klinik für Rheumatologie und Klinische Immunologie, Freiburg, Germany, 9Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark, 10Università degli Studi di Torino, Academic Rheumatology Centre, Turin, Italy, 11Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 12Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 13Marmara University School of Health Sciences, Health Management, Istanbul, Istanbul, Turkey, 14Rheumatology, Reumakliniek Lelystad, Lelystad, Netherlands

    Background/Purpose: Imaging techniques such as salivary gland ultrasound and magnetic resonance imaging (MRI) are able to diagnose primary Sjögren syndrome (pSS) patients with high sensitivity…
  • Abstract Number: 1257 • ACR Convergence 2020

    Gestational Diabetes Mellitus in Pregnant Women with Systemic Lupus Erythematosus

    Sofia Gernaat1, Julia Simard2, Elisabet Svenungsson3 and Elizabeth Arkema4, 1Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 2Stanford Medicine, Stanford, CA, 3Karolinska University Hospital, Stockholm, Sweden, 4Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Increased insulin resistance is pivotal in the development of gestational diabetes mellitus (GDM). Women with SLE may be at higher risk of GDM due…
  • Abstract Number: 1256 • ACR Convergence 2020

    Mast Cells Contribute to the Development of Sialadenitis Associated with Sjögren’s Syndrome via Inducing Tissue Fibrosis by TGFβ Production

    Shinjiro Kaieda1, Kyoko Fujimoto1 and Hiroaki Ida1, 1Kurume University School of Medicine, Kurume, Japan

    Background/Purpose: Mast cells have been implicated in many immune-inflammatory disorders. They mediate a variety of inflammatory and fibrotic conditions, but their role in sialadenitis in…
  • Abstract Number: 1262 • ACR Convergence 2020

    Single LAC Positivity versus Double and Triple Positivity for Thrombosis in SLE

    Selcan Demir1, Jessica Li2, Laurence Magder3 and Michelle Petri4, 1Hacettepe University Faculty of Medicine, Ankara, Ankara, Turkey, 2Johns Hopkins University, Baltimore, MD, 3University of Maryland, Baltimore, Baltimore, MD, 4Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose:Antiphospholipid syndrome (APS) is classified as the development of venous and/or arterial thromboses, and pregnancy morbidity, in the presence of antiphospholipid antibodies (aPL); lupus anticoagulant,…
  • Abstract Number: 1264 • ACR Convergence 2020

    Mortality in Patients with Systemic Lupus Erythematosus and Neuropsychiatric Symptoms

    Rory Monahan1, Rolf Fronczek1, Jeroen Eikenboom1, Huub Middelkoop1, Liesbeth Beaart-van de Voorde1, Gisela Terwindt1, Nic van der Wee1, Frits Rosendaal1, Thomas Huizinga1, Margreet Kloppenburg1 and Margreet Steup-Beekman1, 1Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Little is known about mortality in patients with systemic lupus erythematosus (SLE) presenting with neuropsychiatric (NP) symptoms. We aimed to evaluate all-cause and cause-specific…
  • Abstract Number: 1259 • ACR Convergence 2020

    The Impact of Antimalarial Agents on Traditional and Non-traditional Cardiovascular Markers in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis

    Claudia Mendoza-Pinto1, Mario Garcia-Carrasco1, Pamela Munguía-Realpozo2, Ivet Etchegaray-Morales2 and Socorro Mendez-Martínez1, 1Instituto Mexicano del Seguro Social, Puebla, Puebla, Mexico, 2Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Puebla, Mexico

    Background/Purpose: Cardiovascular morbidity and mortality is a well-established problem in patients with systemic lupus erythematosus (SLE). Hydroxychloroquine (HCQ) has been seen as a potential atheroprotective…
  • Abstract Number: 1254 • ACR Convergence 2020

    Lack of Efficacy of Early Treatment with Hydroxychloroquine in a Group of Hispanics with Primary Sjögren’s Syndrome

    Ariana González-Meléndez1, Patricia Jordán-González1, Ricardo Gago-Piñero1, Noemí Varela-Rosario1, Naydi Pérez-Ríos1 and Luis Vilá1, 1University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

    Background/Purpose: Treatment of primary Sjögren’s syndrome (pSS) with hydroxychloroquine (HCQ) has been evaluated in the past but with conflicting results regarding its efficacy. While earlier…
  • Abstract Number: 1267 • ACR Convergence 2020

    Perceived Stress During the COVID-19 Pandemic Independently Associates with Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE)

    Sarah Patterson1, Laura Trupin2, Kimberly DeQuattro1, Cristina Lanata1, Maria Dall'Era3, Jinoos Yazdany2 and Patricia Katz2, 1UCSF, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Division of Rheumatology, University of California, San Francisco, CA

    Background/Purpose: Causes and risk factors for variations in SLE disease activity and symptom severity are incompletely understood. Prior studies suggest a link between stressful life…
  • Abstract Number: 1270 • ACR Convergence 2020

    Trend of Survival of a Cohort of Patients with Systemic Lupus Erythematosus over 25 Years

    Chi Chiu Mok1, Ling Yin Ho1, Kar Li Chan2, Sau Mei Tse2 and Chi Hung To3, 1Tuen Mun Hospital, Hong Kong, China (People's Republic), 2Tuen Mun Hospital, Hong Kong, Hong Kong, 3Pok Oi Hospital, Hong Kong, Hong Kong

    Background/Purpose: Background: Few studies of systemic lupus erythematosus (SLE) have a follow-up duration long enough to evaluate the time trend of survival, particularly in Asian…
  • Abstract Number: 1271 • ACR Convergence 2020

    Post-Traumatic Stress Disorder (PTSD) and Risk of Systemic Lupus Erythematosus (SLE) Among Medicaid Recipients

    Siobhan Case1, Candace Feldman1, Hongshu Guan1, Laura Kubzansky2, Karestan Koenan2 and Karen Costenbader3, 1Brigham and Women's Hospital, Boston, MA, 2Harvard T.H. Chan School of Public Health, Boston, MA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Post-traumatic stress disorder (PTSD), the sentinel stress-related mental disorder, may be associated with increased risk of developing autoimmune disease, including systemic lupus erythematosus (SLE).…
  • Abstract Number: 1266 • ACR Convergence 2020

    Multivariate Risk Model Shows Different Risk Factors for Myocardial Infarction and Stroke in SLE

    Michelle Petri1, Jessica Li2 and Daniel Goldman1, 1Johns Hopkins University School of Medicine, Timonium, MD, 2Johns Hopkins University, Baltimore, MD

    Background/Purpose: Cardiovascular events remain a major cause of morbidity and mortality in SLE. Accelerated atherosclerosis occurs in SLE and many other inflammatory diseases.  In the…
  • Abstract Number: 1277 • ACR Convergence 2020

    Low Cost Composite Markers to Differentiate Infection from Disease Activity in a Febrile Patient with Systemic Lupus Erythematosus

    Pankti Mehta1, Komal Singh1, Amita Aggarwal1 and Seema Sharma1, 1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at an increased risk of infection owing to immunosuppressive therapy along with coexistent immune dysregulation. It is…
  • Abstract Number: 1274 • ACR Convergence 2020

    COVID-19 in Patients with Systemic Lupus Erythematosus

    Ruth Fernandez-Ruiz1, Mala Masson1, Mimi Kim2, Benjamin Myers3, Rebecca Haberman4, Jose Scher4, Rochelle Castillo4, Allison Guttmann1, Philip Carlucci1, Kristina Deonaraine1, Michael Golpanian5, Kimberly Robins1, Miao Chang1, H. Michael Belmont6, Jill Buyon7, Ashira Blazer6, Amit Saxena8 and Peter Izmirly9, 1New York University School of Medicine, New York, 2Albert Einstein College of Medicine, Bronx, 3Cornell University, Ithica, NY, 4NYU School of Medicine, New York City, 5New York University, New York, NY, 6NYU School of Medicine, New York, NY, 7Department of Medicine, NYU School of Medicine, New York, NY, 8NYU School of Medicine, New York, 9Department of Medicine, New York University School of Medicine, New York, NY

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) represent a unique population in considering risk for coronavirus disease 2019 (COVID-19) with biologic, genetic, demographic, clinical and…
  • Abstract Number: 1269 • ACR Convergence 2020

    Evaluation of a Patient-reported Frailty Tool in Women with Systemic Lupus Erythematosus

    Sarah Lieber1, Stephen Paget1, Jessica Berman1, Medha Barbhaiya2, Lisa Sammaritano2, Kyriakos Kirou1, John Carrino3, Musarrat Nahid4, Mangala Rajan4, Dina Sheira1 and Lisa Mandl1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Barbara Volcker Center for Women and Rheumatic Diseases, New York, NY, 3Hospital for Special Surgery, Hackensack, NJ, 4Weill Cornell Medicine, New York

    Background/Purpose: Frailty has been associated with increased disability and mortality in SLE. To our knowledge, no patient-reported frailty tool has been evaluated alongside a standard…
  • Abstract Number: 1161 • ACR Convergence 2020

    Perspectives of Radiologist Physicians in the Imaging of Chronic Nonbacterial Osteomyelitis

    Farzana Nuruzzaman1, Mingqian Huang2, Christian Hedrich3, Hermann Girschick4, Julie Cherian5, T. Shawn Sato6, Karen Onel7, Polly Ferguson8 and Yongdong Zhao9, 1Stony Brook Children's Hospital, Stony Brook, NY, 2Mount Sinai Hospital, 10003, NY, 3University of Liverpool, Liverpool, United Kingdom, 4Vivantes Children’s Hospital, Wuerzburg, Germany, 5Stony Brook Children�s Hospital, Stony Brook, NY, 6University of Iowa, Iowa City, 7Pediatric Rheumatology, Hospital for Special Surgery, New York, NY, 8University of Iowa Carver College of Medicine, Iowa City, IA, 9University of Washington, Seattle, WA

    Background/Purpose: Radiological imaging is integral to the diagnosis of chronic nonbacterial osteomyelitis (CNO) and has been included as a central component in suggested diagnostic criteria…
  • « Previous Page
  • 1
  • …
  • 709
  • 710
  • 711
  • 712
  • 713
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology